Association of Diabetes Care & Education Specialists

JOIN ADCES

Practice Resources

ADCES Playbook Series:
Implementing CGM Into Your Practice

Continuous glucose monitoring has become a game changer in the quest to achieve glucose management goals. We have partnered with key healthcare stakeholders to create a series of playbooks that give you a step-by-step approach to leveraging this new technology in your practice. 

Personal CGM Implementation Playbook
Developed by ADCES, APhA and APhA Foundation

Personal CGM can be a life-changing tool for someone with diabetes and has become the gold standard for those on an intensive insulin program. Unfortunately, many people with diabetes that could benefit from the use of this technology do not currently have access to it.

The Personal CGM Playbook is a practical tool for diabetes care and education specialists, providing a step-by-step pathway to help you and your practice get started with personal CGM. What you will find: 

  • A background into CGM technology and an overview of the evidence
  • Advantages and disadvantages of CGM
  • Candidate selection and payor considerations
  • Patient and provider barriers to adoption, as well as possible solutions

Professional CGM Implementation Playbook
Developed by ADCES and AANP

ADCESPlaybook2020Updates_Cover

This newly updated toolkit will help you implement a professional CGM program within your health system. Professional CGM programs offer people with diabetes the ability to use CGM devices for short periods of time so both they and their diabetes care team can optimize diabetes self-management through user-generated data. The Professional CGM Playbook was developed in partnership with the American Association of Nurse Practitioners.

Implementing a program within a healthcare setting offers many advantages including:

  • Greater utilization of CGM for people with diabetes who may be reluctant to use CGM but would nevertheless benefit from a comprehensive review of their personal glucose patterns and glycemic variability to better modify behavior.
  • Promotion of self-motivated, data-driven behavior change and improved clinical outcomes through alignment of medication with behavior change resulting in lowered long-term healthcare costs for people with type 1 and type 2 diabetes.
  • Acceleration of the use of personal CGM by building a bridge to individuals who will see the value of the device via a controlled experience.
  • Development of a new revenue stream and sustainability mechanism for health systems and diabetes self-management education and support programs.

Both playbooks were supported by Abbott Diabetes Care and Dexcom.

abbott diabetes care  dexcom-logo 

 

    

In This Section

Practice